journal article·2022-04-23Open access

The Influence of Peripheral Blood Eosinophil Counts in Asthma Comorbidities in Adults: A Real Life Study

Ignacio Esteban-Gorgojo, Manuel Jorge Rial, Joaquín Sastre

Applied Sciences· Volume 12· Issue 9

Abstract

Asthma and eosinophilia are two closely related pathologies whose interaction is key in the era of precision medicine. However, this relationship is rarely taken into account without the influence of therapeutic prescriptions. In this study involving 1296 subjects, the relationship between eosinophilia and asthma was analyzed without taking into account other biases. We observed that rhinitis only appears in non-asthmatic patients with elevated blood eosinophil levels, while atopy was elevated in parallel to eosinophilia regardless of whether the patients were asthmatic or not. In terms of lung function, a decrease was observed for higher blood eosinophil levels, which is especially relevant in the FEV1/FVC ratio. FENO is elevated in relation to higher eosinophilia, but total IgE is only elevated in patients with high peripheral blood eosinophil levels and asthma. Finally, the only feature of asthma that is altered by increased peripheral eosinophilia is persistent asthma, with all other features remaining unchanged.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Asthma and respiratory diseases · Allergic Rhinitis and Sensitization · Respiratory and Cough-Related Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Allergy Department, Hospital General de Villalba, 28400 Madrid, Spain

Allergy Department, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, Spain

CIBER de Enfermedades Respiratorias, Carlos III Health Institute, 28029 Madrid, Spain

Allergy Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain

References (21)

Show source-provided references
1. Lung-resident eosinophils represent a distinct regulatory eosinophil subset10.1172/JCI85664 ↗
2. Eosinophilic Phenotypes of Airway Disease10.1513/AnnalsATS.201306-168AW ↗
3. Severe eosinophilic asthma: A roadmap to consensus10.1183/13993003.00634-2017 ↗
4. Eosinophilic Asthma10.1016/j.jaip.2019.11.024 ↗
5. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines—Recommendations on the use of biologicals in severe asthma10.1111/all.14221 ↗
6. (2022, February 28). 2021 GINA Report, Global Strategy for Asthma Management and Prevention. Available online: https://ginasthma.org/gina-reports/.
7. Standardization of spirometry10.1183/09031936.05.00034805 ↗
8. Multi-ethnic reference values for spirometry for the age range 3 to 95 years: The global lung function equations10.1183/09031936.00080312 ↗
9. American Thoracic Society, and European Respiratory Society (2005). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am. J. Respir. Crit. Care Med., 171, 912–930.10.1164/rccm.200406-710ST ↗
10. (2022, February 14). GEMA Guideline. Available online: https://www.gemasma.com.
11. Food allergy as an asthma comorbidity in children and adolescents: A practical approach through a real-world study10.15586/aei.v49i1.19 ↗
12. Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort10.1002/clt2.12001 ↗
13. Non-eosinophilic asthma: Current perspectives10.2147/JAA.S153097 ↗
14. Rial, M., Cañas, J., Rodrigo-Muñoz, J., Valverde-Monge, M., Sastre, B., Sastre, J., and del Pozo, V. (2021). Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma. Int. J. Mol. Sci., 22.10.3390/ijms22073558 ↗
15. Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement10.18176/jiaci.0638 ↗
16. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study10.1186/s12931-016-0482-9 ↗
17. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma10.1183/09031936.03.00261903 ↗
18. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s severe asthma research program10.1016/j.jaci.2006.11.639 ↗
19. Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma10.1183/13993003.00019-2017 ↗
20. Schleich, F.N., Manise, M., Sele, J., Henket, M., Seidel, L., and Louis, R. (2013). Distribution of sputum cellular phenotype in a large asthma cohort: Predicting factors for eosinophilic vs. neutrophilic inflammation. BMC Pulm. Med., 13.10.1186/1471-2466-13-11 ↗
21. Burte, E., Bousquet, J., Varraso, R., Gormand, F., Just, J., Matran, R., Pin, I., Siroux, V., Jacquemin, B., and Nadif, R. (2015). Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study. PLoS ONE, 10.10.1371/journal.pone.0136191 ↗